iShares Biotechnology ETF
419 hedge funds and large institutions have $6.6B invested in iShares Biotechnology ETF in 2015 Q2 according to their latest regulatory filings, with 65 funds opening new positions, 134 increasing their positions, 150 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
11% less repeat investments, than reductions
Existing positions increased: 134 | Existing positions reduced: 150
65% less call options, than puts
Call options by funds: $665M | Put options by funds: $1.9B
Holders
419
Holding in Top 10
42
Calls
$665M
Puts
$1.9B
Top Buyers
| 1 | +$74.8M | |
| 2 | +$56M | |
| 3 | +$54.6M | |
| 4 |
SG Americas Securities
New York
|
+$37.4M |
| 5 |
MAA
Managed Account Advisors
Jersey City,
New Jersey
|
+$36.4M |
Top Sellers
| 1 | -$148M | |
| 2 | -$143M | |
| 3 | -$110M | |
| 4 |
Morgan Stanley
New York
|
-$67.5M |
| 5 |
JPMorgan Chase & Co
New York
|
-$61.7M |